A case of refractory amyopathic dermatomyositis successfully treated with upadacitinib

Int J Dermatol. 2024 Jul;63(7):959-961. doi: 10.1111/ijd.17135. Epub 2024 Mar 20.

Authors

Vincenzo Maione¹, Stefano Bighetti¹, Sara Rovaris¹, Simonetta Battocchio², Piergiacomo Calzavara-Pinton¹, Luca Bettolini¹

Affiliations

¹ Department of Dermatology, Spedali Civili, University of Brescia, Brescia, Italy.
² Department of Pathology, Spedali Civili, University of Brescia, Brescia, Italy.

PMID: 38504645
DOI: 10.1111/ijd.17135

No abstract available

Keywords: dermatologic therapy; dermatomyositis; immunodermatology.

Publication types

Case Reports
Letter

MeSH terms

Dermatomyositis* / complications
Dermatomyositis* / diagnosis
Dermatomyositis* / drug therapy
Heterocyclic Compounds, 3-Ring* / therapeutic use
Humans
Middle Aged
Treatment Outcome

Substances

Heterocyclic Compounds, 3-Ring
upadacitinib

Supplementary concepts

Amyopathic dermatomyositis